NCT05052463 is a clinical trial of electrolyte imbalance analysis in Electrolyte Imbalance, sponsored by Kecioren Education and Training Hospital.

Who is sponsoring NCT05052463?

NCT05052463 is sponsored by Kecioren Education and Training Hospital.

What drugs are being tested in NCT05052463?

Interventions in NCT05052463: electrolyte imbalance analysis.

What condition does NCT05052463 study?

NCT05052463 studies Electrolyte Imbalance.

Is NCT05052463 still recruiting?

NCT05052463 is currently completed. Last updated 28 September 2021.

Last reviewed 2021-09-28 · How we verify

NCT05052463

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electrolyte Imbalance Analysis at Intensive Care Unit Admission : Retrospective Study

Completed Last updated 28 September 2021

What this trial tests

trial testing electrolyte imbalance analysis in Electrolyte Imbalance in 824 participants. Completed in 15 August 2021.

Timeline

10 December 2019

Primary endpoint
5 April 2021

15 August 2021

Quick facts

Lead sponsor	Kecioren Education and Training Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	824
Start date	10 December 2019
Primary completion	5 April 2021
Estimated completion	15 August 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

electrolyte imbalance analysis

Conditions studied

Electrolyte Imbalance — all drugs for Electrolyte Imbalance →

Sponsor

Kecioren Education and Training Hospital

Who can join

18 and older, any sex, with Electrolyte Imbalance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The type and severity of electrolyte imbalance in patients admitted to the intensive care unit were analyzed.It was evaluated whether these results had an effect on mortality, length of hospital stay, APACHE II scores and ventilator days

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Kecioren Education and Training Hospital trials

Trials by the same sponsor.

NCT05387356 — Evaluation of the Efficiency and Complications of the Consequtive Proning in Covid -19 ICU · unknown
NCT04533568 — Ibuprofen in Migraine Patients · Phase 4 · completed
NCT04712227 — Can the Ratio of Chin-neck Circumference and Neck Circumference to Chin-neck Circumference Predict Difficult Intubation · completed
NCT04362215 — Heart Aging When Near Vision Difficulty Begins · completed
NCT03360045 — Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05052463 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kecioren Education and Training Hospital
Last refreshed: 28 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05052463.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing